NCT04678440 2025-07-02
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
Clinical Trials
25 trialsNCT03755102 2025-05-15
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT05555342 2025-05-14
A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm
University of California, Irvine
Phase EARLY_PHASE1 Completed
NCT04049474 2025-04-24
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT04752267 2024-05-24
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
University of Southern California
Phase EARLY_PHASE1 Completed
NCT02978196 2024-05-17
99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01383135 2024-01-12
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
Phase EARLY_PHASE1 Completed
NCT04267874 2023-12-01
Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT04857697 2023-04-21
Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03858491 2022-09-26
OSIBOOST
Academisch Ziekenhuis Maastricht
Phase EARLY_PHASE1 Completed
NCT03158883 2021-10-20
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT03972228 2021-09-17
Microdevice for Evaluating Drug Response in Site in Lung Lesions
Brigham and Women's Hospital
Phase EARLY_PHASE1 Completed
NCT02357836 2021-05-03
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT02604862 2020-02-13
FIB ONE
University of Edinburgh
Phase EARLY_PHASE1 Completed
NCT04056026 2019-09-23
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
ProgenaBiome
Phase EARLY_PHASE1 Completed
NCT02628080 2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1 Completed
NCT01722149 2019-08-07
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
University of Zurich
Phase EARLY_PHASE1 Completed
NCT02463994 2019-02-08
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT02652286 2016-04-19
Pulmonary Artery Harmonic Ace+7 Energy Sealing in VATS Lobectomy
Centre hospitalier de l'Université de Montréal (CHUM)
Phase EARLY_PHASE1 Completed
NCT02456311 2015-11-26
Pulmonary Artery Harmonic Ace+7 Energy Sealing in Open Lobectomy
Centre hospitalier de l'Université de Montréal (CHUM)
Phase EARLY_PHASE1 Completed
NCT00673283 2014-08-01
Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging
Duke University
Phase EARLY_PHASE1 Completed
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed
NCT00221169 2009-02-05
Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer
Toronto Sunnybrook Regional Cancer Centre
Phase EARLY_PHASE1 Completed
NCT00743353 2009-02-02
K5
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed